Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.

Zang X, Tang H, Min JE, Gu D, Montaner JS, Wu Z, Nosyk B.

PLoS One. 2016 Nov 28;11(11):e0167308. doi: 10.1371/journal.pone.0167308. eCollection 2016.

2.

HIV treatment as prevention: contradictory perspectives from dynamic mathematical models.

Wu J, Norris JL, Jia Y, Wang N.

ScientificWorldJournal. 2014;2014:760734. doi: 10.1155/2014/760734. Epub 2014 Dec 15. Review.

3.

Trends in all-cause mortality during the scale-up of an antiretroviral therapy programme: a cross-sectional study in Lusaka, Zambia.

Rathod SD, Chi BH, Kusanthan T, Chilopa B, Levy J, Sikazwe I, Mwaba P, Stringer JS.

Bull World Health Organ. 2014 Oct 1;92(10):734-41. doi: 10.2471/BLT.13.134239. Epub 2014 Jun 26.

4.

Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.

McCormick AW, Abuelezam NN, Rhode ER, Hou T, Walensky RP, Pei PP, Becker JE, DiLorenzo MA, Losina E, Freedberg KA, Lipsitch M, Seage GR 3rd.

PLoS One. 2014 May 27;9(5):e98272. doi: 10.1371/journal.pone.0098272. eCollection 2014.

5.

Assessing the Public Health impact of HIV interventions: the critical role of demographics.

Dimitrov D, Kuang Y, Mâsse BR.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):e60-2. doi: 10.1097/QAI.0000000000000133. No abstract available.

6.

Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom.

Long EF, Mandalia R, Mandalia S, Alistar SS, Beck EJ, Brandeau ML.

PLoS One. 2014 Apr 24;9(4):e95735. doi: 10.1371/journal.pone.0095735. eCollection 2014.

7.

Male, mobile, and moneyed: loss to follow-up vs. transfer of care in an urban African antiretroviral treatment clinic.

Marson KG, Tapia K, Kohler P, McGrath CJ, John-Stewart GC, Richardson BA, Njoroge JW, Kiarie JN, Sakr SR, Chung MH.

PLoS One. 2013 Oct 24;8(10):e78900. doi: 10.1371/journal.pone.0078900. eCollection 2013.

8.

AIDS and drug rationing.

Sharif PS, Noroozi M.

J Med Ethics Hist Med. 2010 Mar 16;3:1. Print 2010.

9.

Is 2 a "high number of partners"? Modeling, data, and the power of concurrency.

Goodreau SM.

Sex Transm Dis. 2013 Jan;40(1):61. doi: 10.1097/OLQ.0b013e31827b9d8d. No abstract available.

10.

HIV treatment optimism and its predictors among young adults in southern Malawi.

Yeatman S, Dovel K, Conroy A, Namadingo H.

AIDS Care. 2013 Aug;25(8):1018-25. doi: 10.1080/09540121.2012.748168. Epub 2012 Dec 11.

11.

The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.

Juusola JL, Brandeau ML, Owens DK, Bendavid E.

Ann Intern Med. 2012 Apr 17;156(8):541-50. doi: 10.7326/0003-4819-156-8-201204170-00001.

12.

The use of preexposure treatments for HIV prophylaxis.

Majid A, Redfield RR, Gilliam BL.

HIV AIDS (Auckl). 2012;4:17-28. doi: 10.2147/HIV.S25082. Epub 2012 Feb 3.

13.
14.

The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa.

Hontelez JA, de Vlas SJ, Tanser F, Bakker R, Bärnighausen T, Newell ML, Baltussen R, Lurie MN.

PLoS One. 2011;6(7):e21919. doi: 10.1371/journal.pone.0021919. Epub 2011 Jul 20.

15.

The cost-effectiveness of a modestly effective HIV vaccine in the United States.

Long EF, Owens DK.

Vaccine. 2011 Aug 18;29(36):6113-24. doi: 10.1016/j.vaccine.2011.04.013. Epub 2011 Apr 19.

16.

Sexual risk taking among patients on antiretroviral therapy in an urban informal settlement in Kenya: a cross-sectional survey.

Ragnarsson A, Ekström AM, Carter J, Ilako F, Lukhwaro A, Marrone G, Thorson A.

J Int AIDS Soc. 2011 Apr 18;14:20. doi: 10.1186/1758-2652-14-20.

17.

Preexposure prophylaxis for HIV prevention.

Kelesidis T, Landovitz RJ.

Curr HIV/AIDS Rep. 2011 Jun;8(2):94-103. doi: 10.1007/s11904-011-0078-4. Review.

18.
19.

The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.

Long EF, Brandeau ML, Owens DK.

Ann Intern Med. 2010 Dec 21;153(12):778-89. doi: 10.7326/0003-4819-153-12-201012210-00004.

20.

How HIV treatment could result in effective prevention.

Venkatesh KK, Lurie MN, Mayer KH.

Future Virol. 2010 Jul;5(4):405-415.

Supplemental Content

Support Center